TORONTO, Aug. 15, 2023 /CNW/ - Shiny Health & Wellness Corp. ("Shiny Health" or the "Company") (TSXV: SNYB), announces that, the annual general meeting of shareholders of the Company (the 'Meeting') originally scheduled for August 16, 2023 will now take place on August 30, 2023 at 10:00 AM (Pacific time) at the location set forth in the Company's original Notice of Meeting dated July 5th, 2023.
The Company is not proposing to deliver a new Notice of Meeting, Management Information Circular or proxy materials to its shareholders in connection with the postponed Meeting since none of the information in the original versions, copies of which are available on SEDAR, has changed. The new proxy deadline for the Meeting is August 28, 2023 at 11:00 AM (Pacific time).
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release.
Shiny Health & Wellness Corp. is on a mission to help people never settle, live fully by being a trusted source for health and wellness solutions and services. The Company recently broadened its retail growth strategy beyond adult-use cannabis by establishing mīhī Health & Wellness, a new line of business focused on building a network of community pharmacies, with its first pharmacy in Cornwall, Ontario. Striving to provide a more diverse and accessible cannabis experience for adult consumers, the Company also operates ShinyBud Cannabis Co., a well-established brand in Ontario strategically located in markets less saturated with cannabis retailers. The Company's board of directors and management team hold extensive retail operating experience, a key competitive differentiator in leading its growth strategy. Shiny Health trades on the TSX Venture Exchange (TSXV) under the ticker symbol SNYB. For more information, please visit www.shinyhealthandwellness.com
SOURCE Shiny Health & Wellness Corp.
Michael Nadeau, CEO, P: +1 (647) 478-8606 | E: [email protected]; Investor Relations, P: +1 (888) 833-1260 | E: [email protected]
Share this article